Browse > Article
http://dx.doi.org/10.22246/jikm.2020.41.3.293

Development and Validation of Questionnaire for Chronic Fatigue Syndrome (CFS) Diagnosis Based on Systemic Exertion Intolerance Disease (SEID) Criteria  

Lim, Eun-jin (Institute of Bioscience and Integrative Medicine, Dept. of Oriental Medicine College, University of Daejeon)
Son, Chang-gue (Institute of Bioscience and Integrative Medicine, Dept. of Oriental Medicine College, University of Daejeon)
Jang, Eun-su (Institute of Bioscience and Integrative Medicine, Dept. of Oriental Medicine College, University of Daejeon)
Publication Information
The Journal of Internal Korean Medicine / v.41, no.3, 2020 , pp. 293-305 More about this Journal
Abstract
Purpose: This study aimed to develop a questionnaire for the diagnosis of chronic fatigue syndrome (CFS) designed based on the systematic exertion intolerance disorder (SEID) criteria, and to validate the reliability of the questionnaire. Methods: A literature search on questionnaires for CFS diagnosis was conducted to develop a SEID questionnaire (SEID-Q27), followed by a pilot survey to identify the reliability of the questionnaire. Adults (Daejeon university personnel) with a Chalder fatigue scale (CFQ) score ≥15 were invited for the survey. We commenced the survey in November 2019 with a two weeks of interval for the test and retest method. The reliability of the questionnaire was investigated in three angles: 1. Cronbach's α, 2. correlations (r) of the questions, numerical rating scale (NRS), and visual analog scale (VAS), and 3. kappa (k) analysis. Results: Among the total 275 adults registered, 55 (20%) participants with a CFQ score ≥15 were invited, and 31 (11%) [15 male, 16 female] completed the questionnaire. The total Cronbach's α was 0.944 for the test and 0.949 for the retest. The reliability (r) of questions by CFQ score (≥15, ≥18, ≥20) ranged from 0.533-0.928 (p <0.05), and the r score of the NRS and VAS were the highest in CFQ scores ≥20, at 0.933 (p<0.001). The agreement rate of the SEID-Q27 between the test and retest was 87% (kappa k=0.743). Conclusions: The SEID-Q27 seems to be reliable. Further studies are needed to measure the validity of the tool and the cutoff point.
Keywords
chronic fatigue syndrome; systemic exertion intolerance disease; reliability; diagnostic tool; survey questionnaire;
Citations & Related Records
연도 인용수 순위
  • Reference
1 Lim EJ, Ahn YC, Jang ES, Lee SW, Lee SH, Son CG. Systematic review and meta-analysis of the prevalence of chronic fatigue syndrome/myalgic encephalomyelitis (CFS/ME). J Translational Medicine 2020;18(1):100.   DOI
2 Institute of Medicine, Beyond Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: Redefining an Illness. The National Academies of Sciences Engineering Medicine. Institute of medicine(IOM) 2015.
3 Hawk C, Jason LA, Torres-Harding S. Reliability of a chronic fatigue syndrome Questionnaire. Journal of Chronic Fatigue Syndrome 2006;13(4):41-66.   DOI
4 Shin HC. Overview of chronic fatigue syndrome for primary care physicians. Journal of Korean Family Medicine 2001;22(12):1717-42.
5 Nacul LC, Lacerda EM, Pheby D, Campion P, Molokhia M, Fayyaz S, et al. Prevalence of myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) in three regions of England: a repeated cross-sectional study in primary care. BioMed Central Medicine 2011;9:91.
6 Speight N. Myalgic encephalomyelitis/chronic fatigue syndrome: Review of history, clinical features, and controversies. Saudi J Med Med Sci 2013;1(1):11-3.   DOI
7 Christley Y, Duffy T, Martin CR. A review or the definitional criteria for chronic fatigue syndrome. Journal of Evaluation in Clinical Practice 2012;18(1):25-31.   DOI
8 Morris G, Maes M. Case definitions and diagnostic criteria for Myalgic Encephalomyelitis and Chronic fatigue syndrome: from clinical-consensus to evidence-based case definitions. Act Nerv Super Rediviva 2013;55(1-2):64-78.
9 Johnston S, Brenu EW, Staines DR, Marshall-Gradisnik S. The adoption of chronic fatigue syndrome/myalgic encephalomyelitis case definitions to assess prevalence: a systematic review. Ann Epidemiol 2013;23(6):371-6.   DOI
10 최종후, 전새봄. Poll from the beginning to the end. 3rd ed. Paju: 자유아카데미; 2013, p. 77-8.
11 Chalder T, Berelowitz G, Pawlikowska T, Watts L, Wessely S, Wright D, et al. Development of a fatigue scale. J Psychosom Res 1993;37(2):147-53.   DOI
12 Hyde B. Are myalgic encephalomyelitis and chronic fatigue syndrome synonymous?. They Syndrome Sentinel 1999;3:5-8.
13 Jung JH, Park HK. Experiences of illness and socialization of suffering in patients with chronic fatigue syndrome. Korean Association of Health and Medical Sociology 2016;42(42):5-38.
14 Haney E, Smith MB, McDonagh M, Pappas M, Daeges M, Wasson N, et al. Diagnostic Methods for Myalgic Encephalomyelitis/Chronic fatigue syndrome: A systematic review for a National institute of health pathways to prevention workshop. Annals of Internal Medicine 2015;162(12):834-40.   DOI
15 Jason LA, So S, Brown AA, Sunnquist M, Evans M. Test-Retest Reliability of the DePaul Symptom Questionnaire. Fatigue 2015;3(1):16-32.   DOI
16 Dijkers MP, Kropp GC, Esper RM, Yavuzer G, Cullen N, Bakdalieh Y. Reporting on reliability and validity of outcome measures in medical rehabilitation research. Disabil Rehabil 2002;24(16):819-27.   DOI
17 Nijs J, Vaes P, De Meirleir K. The Chronic Fatigue Syndrome Activities and Participation Questionnaire (CFS-APQ): an overview. Occup Ther Int 2005;12(2):107-721.   DOI
18 Vaes JP, McGregor N, Van Hoof E, De Meirleir K. Psychometric properties of the Dutch Chronic Fatigue Syndrome-Activities and Participation Questionnaire (CFS-APQ). Phys Ther 2003;83(5):444-54.   DOI
19 Jason LA, Evans M, Brown M, Porter N, Brown A, Hunnell J, et al. Fatigue Scales and Chronic Fatigue Syndrome: Issues of Sensitivity and Specificity. Disabil Stud Q 2011;31(1):1375.
20 Cella M, Chalder T. Measuring fatigue in clinical and community settings. J Psychosom Res 2010;69(1):17-22.   DOI
21 CFS/ME Working Group. Report to the Chief Medical Officer of an Independent working group. Department of health 2001. Available from; www.doh.gov.uk/cmo/cfsmer